DEC 29, 2020 2:08 PM PST

Injectable Heart Health Tracker Now Picks Up COVID Red Flags

WRITTEN BY: Tara Fernandez

The statistics are a real eye-opener: in the United States, one person dies every 36 seconds from cardiovascular disease. Technologies to monitor heart health in real-time have life-saving potential, particularly that in the event of a heart attack, every second counts. 

In the wake of the COVID-19 pandemic, an FDA-approved injectable cardiac monitor has received a much-needed upgrade—a temperature sensor that can alert physicians to the early signs of a possible infection.

“The patient is at high risk for infection during this global pandemic due to underlying conditions,” said Luigi Di Biase, section head of Electrophysiology, Director of Arrhythmia Services at Montefiore Health System, at BIOTRONIK, the company behind the new tech.

“It is comforting for me and my patients knowing that we will be able to monitor for early signs of potential life-threatening cardiac arrhythmias and infections for up to 5.5 years. Coupled with the workflow advantages, this device is a step forward for injectable cardiac monitors.”

 

 

With the BIOMONITOR, cardiologists will be able to access daily reports on the vitals of their patients, which includes information on their body temperatures and cardiac arrhythmias. In these vulnerable patients, fevers have been linked to an increased risk of a cardiovascular event. Moreover, these patients are particularly susceptible to experiencing severe COVID-19 symptoms, making careful monitoring for the early stages of infection critical. By being able to transmit their health data completely remotely, they can also avoid unnecessary in-person visits to the hospital.

Vital data trends help support the diagnosis for a range of illnesses and, given the additional impact of the current pandemic on cardiac health, we have worked with urgency to advance BIOMONITOR IIIm’s unique sensor technology, said David Hayes, Chief Medical Officer of BIOTRONIK Inc. 

“Patients with cardiac conditions are at an increased risk for worse outcomes from many systemic illnesses, so closer monitoring of these patients may help manage potential symptoms associated with a febrile response, particularly if it can be done safely and remotely.”

Source: BIOTRONIK.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 12, 2021
Clinical & Molecular DX
Tiny Fragments of RNA in the Blood Signal Dementia Risk
OCT 12, 2021
Tiny Fragments of RNA in the Blood Signal Dementia Risk
Scientists have discovered a novel biomarker in the blood that acts as an early warning sign for dementia: microRNA. The ...
NOV 09, 2021
Clinical & Molecular DX
Device Scavenges Body Heat, Allows Crowds to Gather Safely
NOV 09, 2021
Device Scavenges Body Heat, Allows Crowds to Gather Safely
If efforts to maintain public safety amidst the ongoing pandemic have taught us one thing, it’s that we need bette ...
NOV 15, 2021
Cancer
Dogs Get Cancer Too
NOV 15, 2021
Dogs Get Cancer Too
“Cancer” isn’t a word anyone wants to hear from their doctor. However, many dog owners may not conside ...
NOV 12, 2021
Genetics & Genomics
First Results From 100,000 Genomes Project Gives Hundreds Their Answer
NOV 12, 2021
First Results From 100,000 Genomes Project Gives Hundreds Their Answer
The UK's 100,000 Genomes Project has now given hundreds of people a diagnosis for their disease. Many of them have been ...
NOV 23, 2021
Clinical & Molecular DX
Scientists Enter Uncharted Territory of the Cancer Genome, Emerge Victorious
NOV 23, 2021
Scientists Enter Uncharted Territory of the Cancer Genome, Emerge Victorious
Cancer is a genetic disease—it stems from specific changes in the DNA sequences of the cancer cell genome. Over th ...
NOV 23, 2021
Clinical & Molecular DX
Stopping COVID False-Positives From Slipping Through the Cracks
NOV 23, 2021
Stopping COVID False-Positives From Slipping Through the Cracks
False-positive COVID tests results—where the patient isn’t infected but receives a positive result—tri ...
Loading Comments...